How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing?
We chew over all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Wall Street analyst Brian Skorney calls in to explain his one weird trick to fix drug pricing, and STAT’s Helen Branswell stops by to catch us up on the latest Ebola outbreak — and the bold vaccination scheme underway to stop it. Then we talk about 23andMe’s arguably ill-conceived World Cup sponsorship and subject ourselves to another lightning round that quickly devolves into drinking sunscreen and shots of Fireball.
For more on what we discuss, here’s the latest on Ebola; here’s a reaction to the 23andMe campaign; here’s an update on “right to try”; and here’s the news about Valeant’s convicted executive.
